FDA Drug recall D-499-2013
Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist
- FDA Drug
- Class III
- terminated
- Published 2013-06-05
On 2013-06-05 the FDA classified a Class III recall of Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist by Physicians Total Care, citing failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-499-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-03-18 |
| Published | 2013-06-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Physicians Total Care |
| Distribution | MO |
Product
Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA
Reason
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing
Identifiers
| code_info | Physicians Total Care Lots: 6Z4C Exp. 10/31/2013 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-499-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.